{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:45:53Z","timestamp":1794941153230,"version":"4.9.1"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intensive Care Med"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00134-024-07618-x","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T09:02:24Z","timestamp":1725958944000},"page":"1814-1829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Management of cardiogenic shock: state-of-the-art"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8325-250X","authenticated-orcid":false,"given":"Christian","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael Romano","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Jumean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin A.","family":"Krychtiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kollengode","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Dankiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Delmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra-Arias","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabri","family":"Soussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"issue":"14","key":"7618_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/CIRCULATIONAHA.123.064527","volume":"148","author":"R Waksman","year":"2023","unstructured":"Waksman R et al (2023) Standardized definitions for cardiogenic shock research and mechanical circulatory support devices: scientific expert panel from the shock Academic Research Consortium (SHARC). Circulation 148(14):1113\u20131126","journal-title":"Circulation"},{"issue":"16","key":"7618_CR2","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","volume":"136","author":"S van Diepen","year":"2017","unstructured":"van Diepen S et al (2017) Contemporary management of cardiogenic shock: a scientific statement from the american heart association. Circulation 136(16):e232\u2013e268","journal-title":"Circulation"},{"issue":"13","key":"7618_CR3","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1001\/jama.1983.03340130075039","volume":"250","author":"JB Herrick","year":"1983","unstructured":"Herrick JB (1983) Clinical features of sudden obstruction of the coronary arteries. JAMA 250(13):1757\u20131762","journal-title":"JAMA"},{"issue":"3","key":"7618_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archinte.1942.00200150002001","volume":"69","author":"EA Stead","year":"1942","unstructured":"Stead EA, Ebert RV (1942) Shock syndrome produced by failure of the heart. Arch Inter Med 69(3):369\u2013383","journal-title":"Arch Inter Med"},{"issue":"2","key":"7618_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/2048872619894254","volume":"9","author":"U Zeymer","year":"2020","unstructured":"Zeymer U et al (2020) Acute cardiovascular care association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the acute cardiovascular care association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care 9(2):183\u2013197","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"32","key":"7618_CR6","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/eurheartj\/ehz363","volume":"40","author":"H Thiele","year":"2019","unstructured":"Thiele H et al (2019) Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J 40(32):2671\u20132683","journal-title":"Eur Heart J"},{"issue":"36","key":"7618_CR7","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726","journal-title":"Eur Heart J"},{"issue":"1","key":"7618_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.28329","volume":"94","author":"DA Baran","year":"2019","unstructured":"Baran DA et al (2019) SCAI clinical expert consensus statement on the classification of cardiogenic shock: This document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv 94(1):29\u201337","journal-title":"Catheter Cardiovasc Interv"},{"issue":"24","key":"7618_CR9","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1056\/NEJM199406163302406","volume":"330","author":"RM Califf","year":"1994","unstructured":"Califf RM, Bengtson JR (1994) Cardiogenic shock. N Engl J Med 330(24):1724\u20131730","journal-title":"N Engl J Med"},{"issue":"5","key":"7618_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0002-9343(00)00310-7","volume":"108","author":"V Menon","year":"2000","unstructured":"Menon V et al (2000) Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med 108(5):374\u2013380","journal-title":"Am J Med"},{"issue":"1, Part 2","key":"7618_CR11","volume":"11","author":"C Delmas","year":"2019","unstructured":"Delmas C et al (2019) Patients near to cardiogenic shock (CS) but without hypotension have similar prognosis when compared to patients with classic CS: is it time for redefine CS? A FRENSHOCK multicenter registry analysis. Arch Cardiovasc Dis Suppl 11(1, Part 2):e301","journal-title":"Arch Cardiovasc Dis Suppl"},{"issue":"2","key":"7618_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B et al (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119\u2013177","journal-title":"Eur Heart J"},{"issue":"15","key":"7618_CR13","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","volume":"143","author":"TD Henry","year":"2021","unstructured":"Henry TD et al (2021) Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the American Heart Association. Circulation 143(15):e815\u2013e829","journal-title":"Circulation"},{"issue":"7","key":"7618_CR14","first-page":"845","volume":"11","author":"N Narang","year":"2023","unstructured":"Narang N et al (2023) Management of heart failure\u2013related cardiogenic shock: practical Guidance for Clinicians. Heart Fail 11(7):845\u2013851","journal-title":"Heart Fail"},{"issue":"24","key":"7618_CR15","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1093\/eurheartj\/ehab110","volume":"42","author":"U Ceglarek","year":"2021","unstructured":"Ceglarek U et al (2021) The novel cystatin C, lactate, interleukin-6, and N-terminal pro-B-type natriuretic peptide (CLIP)-based mortality risk score in cardiogenic shock after acute myocardial infarction. Eur Heart J 42(24):2344\u20132352","journal-title":"Eur Heart J"},{"key":"7618_CR16","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2021.32","volume":"8","author":"M Bertaina","year":"2022","unstructured":"Bertaina M et al (2022) Pulmonary artery catheter monitoring in patients with cardiogenic shock: time for a reappraisal? Card Fail Rev 8:e15","journal-title":"Card Fail Rev"},{"issue":"11","key":"7618_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.jchf.2020.08.013","volume":"8","author":"JC Fang","year":"2020","unstructured":"Fang JC, Jones TL (2020) Can a pulmonary artery catheter improve outcomes in cardiogenic shock? JACC Heart Fail 8(11):914\u2013916","journal-title":"JACC Heart Fail"},{"issue":"13","key":"7618_CR18","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1001\/jama.294.13.1664","volume":"294","author":"MR Shah","year":"2005","unstructured":"Shah MR et al (2005) Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294(13):1664\u20131670","journal-title":"JAMA"},{"issue":"11","key":"7618_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jchf.2020.08.012","volume":"8","author":"AR Garan","year":"2020","unstructured":"Garan AR et al (2020) Complete hemodynamic profiling with pulmonary artery catheters in cardiogenic shock is associated with lower in-hospital mortality. JACC Heart Fail 8(11):903\u2013913","journal-title":"JACC Heart Fail"},{"issue":"4","key":"7618_CR20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/MCC.0000000000000853","volume":"27","author":"P Bertini","year":"2021","unstructured":"Bertini P, Guarracino F (2021) Pathophysiology of cardiogenic shock. Curr Opin Crit Care 27(4):409\u2013415","journal-title":"Curr Opin Crit Care"},{"issue":"4","key":"7618_CR21","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1093\/ehjacc\/zuac021","volume":"11","author":"KA Krychtiuk","year":"2022","unstructured":"Krychtiuk KA et al (2022) Basic mechanisms in cardiogenic shock: part 1-definition and pathophysiology. Eur Heart J Acute Cardiovasc Care 11(4):356\u2013365","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"1","key":"7618_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-131-1-199907060-00010","volume":"131","author":"SM Hollenberg","year":"1999","unstructured":"Hollenberg SM, Kavinsky CJ, Parrillo JE (1999) Cardiogenic shock. Ann Intern Med 131(1):47\u201359","journal-title":"Ann Intern Med"},{"issue":"7","key":"7618_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/ejhf.1204","volume":"20","author":"VP Harjola","year":"2018","unstructured":"Harjola VP et al (2018) Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 20(7):1081\u20131099","journal-title":"Eur J Heart Fail"},{"key":"7618_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000001066","author":"D Sarma","year":"2023","unstructured":"Sarma D, Jentzer JC, Soussi S (2023) Cardiogenic shock: a major challenge for the clinical trialist. Curr Opin Crit Care. https:\/\/doi.org\/10.1097\/MCC.0000000000001066","journal-title":"Curr Opin Crit Care"},{"key":"7618_CR25","doi-asserted-by":"crossref","unstructured":"Berg DD et al (2019) Epidemiology of shock in contemporary cardiac intensive care units: data from the critical care cardiology trials network registry. Circulation: Cardiovasc Qual Outcomes 12(3): e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618"},{"issue":"10","key":"7618_CR26","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cardfail.2021.08.014","volume":"27","author":"AS Bhatt","year":"2021","unstructured":"Bhatt AS et al (2021) De novo vs acute-on-chronic presentations of heart failure-related cardiogenic shock: insights from the critical care cardiology trials network registry. J Cardiac Fail 27(10):1073\u20131081","journal-title":"J Cardiac Fail"},{"key":"7618_CR27","doi-asserted-by":"crossref","unstructured":"Jentzer JC et al (2020) Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients. Circulation: Cardiovasc Qual Outcomes 13(12): e006956","DOI":"10.1161\/CIRCOUTCOMES.120.006956"},{"issue":"3","key":"7618_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.chest.2021.09.032","volume":"161","author":"B Burstein","year":"2022","unstructured":"Burstein B et al (2022) Biventricular function and shock severity predict mortality in cardiac ICU patients. Chest 161(3):697\u2013709","journal-title":"Chest"},{"issue":"9","key":"7618_CR29","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"SS Naidu","year":"2022","unstructured":"Naidu SS et al (2022) SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol 79(9):933\u2013946","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"7618_CR30","doi-asserted-by":"publisher","first-page":"100120","DOI":"10.1016\/j.jacadv.2022.100120","volume":"1","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC et al (2022) Advances in the staging and phenotyping of cardiogenic shock: part 1 of 2. JACC Adv 1(4):100120","journal-title":"JACC Adv"},{"key":"7618_CR31","doi-asserted-by":"crossref","unstructured":"Lawler PR, Mehra MR (2018) Advancing from a \u201chemodynamic model\u201d to a \u201cmechanistic disease-modifying model\u201d of cardiogenic shock. Elsevier. 1285\u20131288","DOI":"10.1016\/j.healun.2018.07.009"},{"issue":"1","key":"7618_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40635-023-00531-5","volume":"11","author":"S Soussi","year":"2023","unstructured":"Soussi S et al (2023) Distinct host-response signatures in circulatory shock: a narrative review. Intens Care Med Exp 11(1):50","journal-title":"Intens Care Med Exp"},{"key":"7618_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14596","author":"S Soussi","year":"2023","unstructured":"Soussi S et al (2023) Clinical phenotypes of cardiogenic shock survivors: insights into late host responses and long-term outcomes. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.14596","journal-title":"ESC Heart Fail"},{"issue":"14","key":"7618_CR34","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020085","volume":"10","author":"E Zweck","year":"2021","unstructured":"Zweck E et al (2021) Phenotyping cardiogenic shock. J Am Heart Assoc 10(14):e020085","journal-title":"J Am Heart Assoc"},{"key":"7618_CR35","doi-asserted-by":"publisher","unstructured":"Zweck E et al (2023) Clinical course of patients in cardiogenic shock stratified by phenotype. JACC: Heart Fail https:\/\/doi.org\/10.1016\/j.jchf.2023.05.007","DOI":"10.1016\/j.jchf.2023.05.007"},{"issue":"4","key":"7618_CR36","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/ccd.30103","volume":"99","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC et al (2022) Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population. Catheter Cardiovasc Interv 99(4):1006\u20131014","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"7618_CR37","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1002\/ejhf.2346","volume":"23","author":"WC Meijers","year":"2021","unstructured":"Meijers WC et al (2021) Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC). Eur J Heart Fail 23(10):1610\u20131632","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"7618_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/ALN.0000000000003600","volume":"134","author":"S Soussi","year":"2021","unstructured":"Soussi S et al (2021) Evaluation of biomarkers in critical care and perioperative medicine: a clinician\u2019s overview of traditional statistical methods and machine learning algorithms. Anesthesiology 134(1):15\u201325","journal-title":"Anesthesiology"},{"key":"7618_CR39","doi-asserted-by":"crossref","unstructured":"Jentzer JC et al. (2022) Machine learning approaches for phenotyping in cardiogenic shock and critical illness: part 2 of 2. JACC: Adv 1(4): 100126","DOI":"10.1016\/j.jacadv.2022.100126"},{"key":"7618_CR40","doi-asserted-by":"crossref","unstructured":"Mebazaa A, Soussi S (2023) Precision medicine in cardiogenic shock: we are almost there! 2023, American College of Cardiology Foundation Washington DC. p. 1316\u20131319","DOI":"10.1016\/j.jchf.2023.06.024"},{"issue":"6","key":"7618_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000000906","volume":"43","author":"JL Vincent","year":"2015","unstructured":"Vincent JL (2015) Serial blood lactate levels reflect both lactate production and clearance. Crit Care Med 43(6):e209","journal-title":"Crit Care Med"},{"issue":"4","key":"7618_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MCC.0000000000000628","volume":"25","author":"G Fuernau","year":"2019","unstructured":"Fuernau G (2019) Lactate and other biomarkers as treatment target in cardiogenic shock. Curr Opin Crit Care 25(4):403\u2013409","journal-title":"Curr Opin Crit Care"},{"issue":"19","key":"7618_CR43","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jcin.2020.06.037","volume":"13","author":"G Fuernau","year":"2020","unstructured":"Fuernau G et al (2020) Arterial lactate in cardiogenic shock: prognostic value of clearance versus single values. JACC Cardiovasc Interv 13(19):2208\u20132216","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"7618_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40560-021-00571-7","volume":"9","author":"IH Park","year":"2021","unstructured":"Park IH et al (2021) Clinical significance of lactate clearance in patients with cardiogenic shock: results from the RESCUE registry. J Intens Care 9(1):63","journal-title":"J Intens Care"},{"key":"7618_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jcrc.2017.06.022","volume":"42","author":"I Slottosch","year":"2017","unstructured":"Slottosch I et al (2017) Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock. J Crit Care 42:35\u201341","journal-title":"J Crit Care"},{"issue":"1","key":"7618_CR46","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-024-01266-6","volume":"14","author":"B Levy","year":"2024","unstructured":"Levy B et al (2024) Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study. Ann Intens Care 14(1):43","journal-title":"Ann Intens Care"},{"issue":"10","key":"7618_CR47","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cardfail.2014.07.002","volume":"20","author":"M Alkhouli","year":"2014","unstructured":"Alkhouli M et al (2014) Clinical utility of central venous saturation for the calculation of cardiac index in cardiac patients. J Card Fail 20(10):716\u2013722","journal-title":"J Card Fail"},{"issue":"3","key":"7618_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MAT.0000000000001215","volume":"67","author":"CI McDonald","year":"2021","unstructured":"McDonald CI et al (2021) Elevated venous to arterial carbon dioxide gap and anion gap are associated with poor outcome in cardiogenic shock requiring extracorporeal membrane oxygenation support. ASAIO J 67(3):263\u2013269","journal-title":"ASAIO J"},{"key":"7618_CR49","doi-asserted-by":"crossref","unstructured":"Mathew R et al (2022) Optimal perfusion targets in cardiogenic shock. JACC: Adv 1(2): 100034","DOI":"10.1016\/j.jacadv.2022.100034"},{"issue":"2","key":"7618_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(01)01070-1","volume":"112","author":"M Koreny","year":"2002","unstructured":"Koreny M et al (2002) Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med 112(2):115\u2013119","journal-title":"Am J Med"},{"key":"7618_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijcard.2015.04.242","volume":"191","author":"G Fuernau","year":"2015","unstructured":"Fuernau G et al (2015) Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Int J Cardiol 191:159\u2013166","journal-title":"Int J Cardiol"},{"issue":"10","key":"7618_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/ehjacc\/zuad076","volume":"12","author":"BN Beer","year":"2023","unstructured":"Beer BN et al (2023) Incidence of hypoxic hepatitis in patients with cardiogenic shock and association with mortality. Eur Heart J Acute Cardiovasc Care 12(10):663\u2013670","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"5","key":"7618_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00392-016-1060-3","volume":"106","author":"C Jung","year":"2017","unstructured":"Jung C et al (2017) Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol 106(5):341\u2013349","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"7618_CR54","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1097\/CCM.0b013e31819fe896","volume":"37","author":"R Jarai","year":"2009","unstructured":"Jarai R et al (2009) Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Crit Care Med 37(6):1837\u20131844","journal-title":"Crit Care Med"},{"issue":"9","key":"7618_CR55","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3390\/jpm13091348","volume":"13","author":"T Schupp","year":"2023","unstructured":"Schupp T et al (2023) Cardiac Troponin I but not N-Terminal Pro-B-Type natriuretic peptide predicts outcomes in cardiogenic shock. J Pers Med 13(9):1348","journal-title":"J Pers Med"},{"issue":"1","key":"7618_CR56","volume":"6","author":"H Aminiahidashti","year":"2018","unstructured":"Aminiahidashti H et al (2018) Applications of End-Tidal Carbon Dioxide (ETCO2) monitoring in emergency department; a narrative review. Emerg (Tehran) 6(1):e5","journal-title":"Emerg (Tehran)"},{"issue":"5","key":"7618_CR57","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.cardfail.2022.10.425","volume":"29","author":"JA Ortega-Hernandez","year":"2023","unstructured":"Ortega-Hernandez JA et al (2023) Dynamic invasive hemodynamic congestion profile impacts acute myocardial infarction complicated by cardiogenic shock outcomes: a real-world single-center study. J Card Fail 29(5):745\u2013756","journal-title":"J Card Fail"},{"key":"7618_CR58","doi-asserted-by":"crossref","unstructured":"Lim HS (2020) Cardiac power output revisited. Circulation: Heart Fail 13(10): e007393","DOI":"10.1161\/CIRCHEARTFAILURE.120.007393"},{"issue":"3","key":"7618_CR59","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/MCC.0000000000000937","volume":"28","author":"VK Arya","year":"2022","unstructured":"Arya VK, Al-Moustadi W, Dutta V (2022) Cardiac output monitoring - invasive and noninvasive. Curr Opin Crit Care 28(3):340\u2013347","journal-title":"Curr Opin Crit Care"},{"issue":"1","key":"7618_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13054-017-1737-7","volume":"21","author":"P Mercado","year":"2017","unstructured":"Mercado P et al (2017) Transthoracic echocardiography: an accurate and precise method for estimating cardiac output in the critically ill patient. Crit Care 21(1):136","journal-title":"Crit Care"},{"issue":"6","key":"7618_CR61","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s00134-019-05604-2","volume":"45","author":"A Vieillard-Baron","year":"2019","unstructured":"Vieillard-Baron A et al (2019) A decade of progress in critical care echocardiography: a narrative review. Intens Care Med 45(6):770\u2013788","journal-title":"Intens Care Med"},{"issue":"5","key":"7618_CR62","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00134-023-07023-w","volume":"49","author":"A Wong","year":"2023","unstructured":"Wong A, Chew M, Hernandez G (2023) Using ultrasound in ICU. Intens Care Med 49(5):563\u2013565","journal-title":"Intens Care Med"},{"issue":"10","key":"7618_CR63","volume":"14","author":"G Morales","year":"2022","unstructured":"Morales G et al (2022) Feasibility of very early identification of cardiogenic shock by semi-automated ultrasound exam in the emergency department. Cureus 14(10):e30927","journal-title":"Cureus"},{"issue":"Suppl 1","key":"7618_CR64","first-page":"53","volume":"19","author":"GM Raffa","year":"2017","unstructured":"Raffa GM et al (2017) In-hospital outcome of post-cardiotomy extracorporeal life support in adult patients: the 2007\u20132017 Maastricht experience. Crit Care Resusc 19(Suppl 1):53\u201361","journal-title":"Crit Care Resusc"},{"key":"7618_CR65","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.resuscitation.2014.11.034","volume":"90","author":"B Redfors","year":"2015","unstructured":"Redfors B et al (2015) Angiographic findings and survival in patients undergoing coronary angiography due to sudden cardiac arrest in Western Sweden. Resuscitation 90:13\u201320","journal-title":"Resuscitation"},{"issue":"9905","key":"7618_CR66","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","volume":"382","author":"H Thiele","year":"2013","unstructured":"Thiele H et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. The Lancet 382(9905):1638\u20131645","journal-title":"The Lancet"},{"key":"7618_CR67","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","volume":"389","author":"H Thiele","year":"2023","unstructured":"Thiele H et al (2023) Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med 389:1286\u20131297","journal-title":"N Engl J Med"},{"issue":"4","key":"7618_CR68","first-page":"341","volume":"9","author":"SA Wayangankar","year":"2016","unstructured":"Wayangankar SA et al (2016) Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. Cardiovasc Interv 9(4):341\u2013351","journal-title":"Cardiovasc Interv"},{"issue":"4","key":"7618_CR69","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1001\/jama.294.4.448","volume":"294","author":"A Babaev","year":"2005","unstructured":"Babaev A et al (2005) Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294(4):448\u2013454","journal-title":"JAMA"},{"issue":"16","key":"7618_CR70","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.3390\/jcm12165221","volume":"12","author":"EJ Peters","year":"2023","unstructured":"Peters EJ et al (2023) Characteristics, treatment strategies and outcome in cardiogenic shock complicating acute myocardial infarction: a contemporary Dutch Cohort. J Clin Med 12(16):5221","journal-title":"J Clin Med"},{"key":"7618_CR71","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00392-020-01781-z","volume":"110","author":"CN Lang","year":"2021","unstructured":"Lang CN et al (2021) Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007\u20132017-insights from a national registry. Clin Res Cardiol 110:1421\u20131430","journal-title":"Clin Res Cardiol"},{"key":"7618_CR72","doi-asserted-by":"crossref","unstructured":"Killip III T, Kimball JT (1967) Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 20(4): 457\u2013464","DOI":"10.1016\/0002-9149(67)90023-9"},{"issue":"6","key":"7618_CR73","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1002\/ehf2.14510","volume":"10","author":"M Bertaina","year":"2023","unstructured":"Bertaina M et al (2023) Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction. ESC Heart Fail 10(6):3472\u20133482","journal-title":"ESC Heart Fail"},{"key":"7618_CR74","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00392-017-1182-2","volume":"107","author":"M Shah","year":"2018","unstructured":"Shah M et al (2018) Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 107:287\u2013303","journal-title":"Clin Res Cardiol"},{"issue":"11","key":"7618_CR75","first-page":"879","volume":"8","author":"BN Tehrani","year":"2020","unstructured":"Tehrani BN et al (2020) A standardized and comprehensive approach to the management of cardiogenic shock. Heart Fail 8(11):879\u2013891","journal-title":"Heart Fail"},{"issue":"2","key":"7618_CR76","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/SHK.0000000000001052","volume":"50","author":"HS Lim","year":"2018","unstructured":"Lim HS, Howell N (2018) Cardiogenic shock due to end-stage heart failure and acute myocardial infarction: characteristics and outcome of temporary mechanical circulatory support. Shock 50(2):167\u2013172","journal-title":"Shock"},{"issue":"39","key":"7618_CR77","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","volume":"44","author":"V Delgado","year":"2023","unstructured":"Delgado V et al (2023) 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). Eur Heart J 44(39):3948\u20134042","journal-title":"Eur Heart J"},{"issue":"6","key":"7618_CR78","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.amjmed.2014.12.009","volume":"128","author":"S Bangalore","year":"2015","unstructured":"Bangalore S et al (2015) Outcomes with invasive vs conservative management of cardiogenic shock complicating acute myocardial infarction. Am J Med 128(6):601\u2013608","journal-title":"Am J Med"},{"issue":"9","key":"7618_CR79","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJM199908263410901","volume":"341","author":"JS Hochman","year":"1999","unstructured":"Hochman JS et al (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341(9):625\u2013634","journal-title":"N Engl J Med"},{"issue":"38","key":"7618_CR80","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J 44(38):3720\u20133826","journal-title":"Eur Heart J"},{"issue":"12","key":"7618_CR81","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/ehjacc\/zuad108","volume":"12","author":"FX Herion","year":"2023","unstructured":"Herion FX et al (2023) Multidisciplinary cardiogenic shock team approach improves the long-term outcomes of patients suffering from refractory cardiogenic shock treated with short-term mechanical circulatory support. Eur Heart J Acute Cardiovasc Care 12(12):821\u2013830","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"7618_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuae040","author":"CJ Van Edom","year":"2024","unstructured":"Van Edom CJ et al (2024) European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: A survey of the Association for Acute CardioVascular Care (ACVC) of the ESC and the European branch of the Extracorporeal Life Support Organization (EuroELSO). Eur Heart J Acute Cardiovasc Care. https:\/\/doi.org\/10.1093\/ehjacc\/zuae040","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"9","key":"7618_CR83","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/ehjacc\/zuac087","volume":"11","author":"G Tavazzi","year":"2022","unstructured":"Tavazzi G et al (2022) Epidemiology, monitoring, and treatment strategy in cardiogenic shock. A multinational cross-sectional survey of ESC-acute cardiovascular care association research section. Eur Heart J Acute Cardiovasc Care 11(9):706\u2013711","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"14","key":"7618_CR84","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","volume":"367","author":"H Thiele","year":"2012","unstructured":"Thiele H et al (2012) Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367(14):1287\u20131296","journal-title":"N Engl J Med"},{"issue":"2","key":"7618_CR85","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.resuscitation.2005.01.012","volume":"66","author":"M Ruiz-Bail\u00e9n","year":"2005","unstructured":"Ruiz-Bail\u00e9n M et al (2005) Reversible myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 66(2):175\u2013181","journal-title":"Resuscitation"},{"key":"7618_CR86","doi-asserted-by":"crossref","unstructured":"Thayer KL et al (2020) Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circulation: Heart Fail 13(9): e007099","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099"},{"issue":"4","key":"7618_CR87","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa2204511","volume":"388","author":"MM Suverein","year":"2023","unstructured":"Suverein MM et al (2023) Early extracorporeal CPR for refractory out-of-hospital cardiac arrest. N Engl J Med 388(4):299\u2013309","journal-title":"N Engl J Med"},{"issue":"1","key":"7618_CR88","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/ehjacc\/zuaa003","volume":"10","author":"E Collado","year":"2021","unstructured":"Collado E et al (2021) Hospitalization-related economic impact of patients with cardiogenic shock in a high-complexity reference centre. Eur Heart J Acute Cardiovasc Care 10(1):50\u201353","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"9","key":"7618_CR89","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jamainternmed.2022.2735","volume":"182","author":"PE Miller","year":"2022","unstructured":"Miller PE et al (2022) Clinical outcomes and cost associated with an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump in patients presenting with acute myocardial infarction complicated by cardiogenic shock. JAMA Intern Med 182(9):926\u2013933","journal-title":"JAMA Intern Med"},{"issue":"6","key":"7618_CR90","first-page":"101177","volume":"2","author":"A Malik","year":"2023","unstructured":"Malik A et al (2023) National trends for temporary mechanical circulatory support utilization in patients with cardiogenic shock from decompensated chronic heart failure: incidence, predictors, outcomes, and cost. J Soc Cardiovasc Angiogr Interv 2(6):101177","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"13","key":"7618_CR91","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.jacc.2021.07.044","volume":"78","author":"I Papolos Alexander","year":"2021","unstructured":"Papolos Alexander I et al (2021) Management and outcomes of cardiogenic shock in cardiac ICUs with versus without shock teams. J Am Coll Cardiol 78(13):1309\u20131317","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"7618_CR92","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/03913988211070841","volume":"45","author":"FL Scolari","year":"2022","unstructured":"Scolari FL et al (2022) Cardiogenic shock treated with temporary mechanical circulatory support in Brazil: The effect of learning curve. Int J Artif Organs 45(3):292\u2013300","journal-title":"Int J Artif Organs"},{"issue":"15","key":"7618_CR93","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/heartjnl-2016-310403","volume":"103","author":"J Ledwoch","year":"2017","unstructured":"Ledwoch J et al (2017) Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock. Heart 103(15):1177\u20131184","journal-title":"Heart"},{"key":"7618_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154024","volume":"69","author":"M Bertaina","year":"2022","unstructured":"Bertaina M et al (2022) Prognostic implications of pulmonary artery catheter monitoring in patients with cardiogenic shock: a systematic review and meta-analysis of observational studies. J Crit Care 69:154024","journal-title":"J Crit Care"},{"issue":"13","key":"7618_CR95","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W et al (2022) Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 387(13):1185\u20131195","journal-title":"N Engl J Med"},{"issue":"22","key":"7618_CR96","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/eurheartj\/ehad217","volume":"44","author":"JC Trull\u00e0s","year":"2023","unstructured":"Trull\u00e0s JC, Casado J, Morales-Rull JL (2023) Combination diuretic therapy in acute heart failure. Eur Heart J 44(22):2047\u20132047","journal-title":"Eur Heart J"},{"issue":"3","key":"7618_CR97","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1001\/jama.2022.23924","volume":"329","author":"RJ Mentz","year":"2023","unstructured":"Mentz RJ et al (2023) Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial. JAMA 329(3):214\u2013223","journal-title":"JAMA"},{"key":"7618_CR98","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07374-y","author":"E Kattan","year":"2024","unstructured":"Kattan E, Ibarra-Estrada M, Jung C (2024) Knowing the ropes of vasopressor dosing: a focus on norepinephrine. Intens Care Med. https:\/\/doi.org\/10.1007\/s00134-024-07374-y","journal-title":"Intens Care Med"},{"issue":"3","key":"7618_CR99","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1002\/ehf2.13893","volume":"9","author":"X Lu","year":"2022","unstructured":"Lu X et al (2022) Norepinephrine use in cardiogenic shock patients is associated with increased 30 day mortality. ESC Heart Fail 9(3):1875\u20131883","journal-title":"ESC Heart Fail"},{"issue":"6","key":"7618_CR100","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s00134-018-5214-9","volume":"44","author":"A Mebazaa","year":"2018","unstructured":"Mebazaa A et al (2018) Management of cardiogenic shock complicating myocardial infarction. Intens Care Med 44(6):760\u2013773","journal-title":"Intens Care Med"},{"issue":"8","key":"7618_CR101","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00392-009-0018-0","volume":"98","author":"C Jung","year":"2009","unstructured":"Jung C et al (2009) Acute microflow changes after stop and restart of intra-aortic balloon pump in cardiogenic shock. Clin Res Cardiol 98(8):469\u2013475","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"7618_CR102","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ccd.29895","volume":"99","author":"MB Basir","year":"2022","unstructured":"Basir MB et al (2022) Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock. Catheter Cardiovasc Interv 99(3):650\u2013657","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"7618_CR103","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/SHK.0000000000000579","volume":"46","author":"A Beurton","year":"2016","unstructured":"Beurton A et al (2016) Beneficial effects of norepinephrine alone on cardiovascular function and tissue oxygenation in a pig model of cardiogenic shock. Shock 46(2):214\u2013218","journal-title":"Shock"},{"issue":"4","key":"7618_CR104","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/cc7954","volume":"13","author":"P Asfar","year":"2009","unstructured":"Asfar P, Radermacher P (2009) Vasopressin and ischaemic heart disease: more than coronary vasoconstriction? Crit Care 13(4):169","journal-title":"Crit Care"},{"key":"7618_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108230","volume":"240","author":"RR Bruno","year":"2022","unstructured":"Bruno RR et al (2022) Pharmacological treatment of cardiogenic shock\u2013A state of the art review. Pharmacol Ther 240:108230","journal-title":"Pharmacol Ther"},{"issue":"2","key":"7618_CR106","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00134-022-06905-9","volume":"49","author":"C Cleasby","year":"2023","unstructured":"Cleasby C et al (2023) The effect of vasopressin and hydrocortisone on cytokine trajectories. Intens Care Med 49(2):241\u2013243","journal-title":"Intens Care Med"},{"issue":"8","key":"7618_CR107","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/ejhf.1922","volume":"22","author":"O Chioncel","year":"2020","unstructured":"Chioncel O et al (2020) Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 22(8):1315\u20131341","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"7618_CR108","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13613-021-00806-8","volume":"11","author":"TWL Scheeren","year":"2021","unstructured":"Scheeren TWL et al (2021) Current use of inotropes in circulatory shock. Ann Intens Care 11(1):21","journal-title":"Ann Intens Care"},{"key":"7618_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.696138","volume":"8","author":"F Gao","year":"2021","unstructured":"Gao F, Zhang Y (2021) Inotrope use and intensive care unit mortality in patients with cardiogenic shock: an analysis of a large electronic intensive care unit database. Front Cardiovasc Med 8:696138","journal-title":"Front Cardiovasc Med"},{"issue":"7","key":"7618_CR110","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/jcm9072051","volume":"9","author":"M Karami","year":"2020","unstructured":"Karami M et al (2020) Vasopressors and inotropes in acute myocardial infarction related cardiogenic shock: a systematic review and meta-analysis. J Clin Med 9(7):2051","journal-title":"J Clin Med"},{"key":"7618_CR111","doi-asserted-by":"crossref","unstructured":"Uhlig K et al (2020) Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev 11(11): Cd009669","DOI":"10.1002\/14651858.CD009669.pub4"},{"issue":"27","key":"7618_CR112","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37(27):2129\u20132200","journal-title":"Eur Heart J"},{"key":"7618_CR113","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force M et al. (2021) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail, 24(1): p. 4\u2013131","DOI":"10.1002\/ejhf.2333"},{"issue":"9328","key":"7618_CR114","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F et al (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360(9328):196\u2013202","journal-title":"Lancet"},{"key":"7618_CR115","unstructured":"Rokyta R, Pechman V (2006) The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock. Neuro Endocrinol Lett 27(1\u20132): 121\u20137"},{"issue":"3","key":"7618_CR116","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/eurjhf\/hfn045","volume":"11","author":"A Mebazaa","year":"2009","unstructured":"Mebazaa A et al (2009) Levosimendan vs dobutamine: outcomes for acute heart failure patients on \u03b2-blockers in SURVIVE. Eur J Heart Fail 11(3):304\u2013311","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"7618_CR117","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","volume":"72","author":"B Levy","year":"2018","unstructured":"Levy B et al (2018) Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 72(2):173\u2013182","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"7618_CR118","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1056\/NEJMoa2026845","volume":"385","author":"R Mathew","year":"2021","unstructured":"Mathew R et al (2021) Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med 385(6):516\u2013525","journal-title":"N Engl J Med"},{"key":"7618_CR119","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ahj.2023.04.010","volume":"262","author":"S Parlow","year":"2023","unstructured":"Parlow S et al (2023) Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial. Am Heart J 262:83\u201389","journal-title":"Am Heart J"},{"issue":"2","key":"7618_CR120","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00134-022-06947-z","volume":"49","author":"LC Pladet","year":"2023","unstructured":"Pladet LC et al (2023) Prognostic models for mortality risk in patients requiring ECMO. Intens Care Med 49(2):131\u2013141","journal-title":"Intens Care Med"},{"issue":"3","key":"7618_CR121","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jamainternmed.2022.6168","volume":"183","author":"C Vandenbriele","year":"2023","unstructured":"Vandenbriele C, Tavazzi G, Price S (2023) Caution with conclusions and context of mechanical circulatory devices. JAMA Intern Med 183(3):277","journal-title":"JAMA Intern Med"},{"issue":"1","key":"7618_CR122","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/CCM.0b013e3181b78671","volume":"38","author":"R Prondzinsky","year":"2010","unstructured":"Prondzinsky R et al (2010) Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock - the prospective, randomized IABP SHOCK Trial for attenuation of multi-organ dysfunction syndrome. Crit Care Med 38(1):152\u2013160","journal-title":"Crit Care Med"},{"issue":"4","key":"7618_CR123","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/SHK.0b013e31824a67af","volume":"37","author":"R Prondzinsky","year":"2012","unstructured":"Prondzinsky R et al (2012) Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock 37(4):378\u2013384","journal-title":"Shock"},{"key":"7618_CR124","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(13)61783-3","volume":"382","author":"H Thiele","year":"2013","unstructured":"Thiele H et al (2013) Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock. Final 12-month results of the randomised IntraAortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) Trial. Lancet 382:1638\u20131645","journal-title":"Lancet"},{"issue":"9","key":"7618_CR125","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.healun.2009.05.010","volume":"28","author":"CA den Uil","year":"2009","unstructured":"den Uil CA et al (2009) Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. J Heart Lung Transplant 28(9):906\u2013911","journal-title":"J Heart Lung Transplant"},{"issue":"19","key":"7618_CR126","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.jacc.2008.05.065","volume":"52","author":"M Seyfarth","year":"2008","unstructured":"Seyfarth M et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584\u20131588","journal-title":"J Am Coll Cardiol"},{"key":"7618_CR127","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","volume":"69","author":"DM Ouweneel","year":"2017","unstructured":"Ouweneel DM et al (2017) Impella CP versus intra-aortic balloon pump support in acute myocardial infarction complicated by cardiogenic shock. The IMPRESS in Severe Shock trial. J Am Coll Card 69:278\u2013287","journal-title":"J Am Coll Card"},{"key":"7618_CR128","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","volume":"139","author":"B Schrage","year":"2019","unstructured":"Schrage B et al (2019) Impella support for acute myocardial infarction complicated by cardiogenic shock: a matched-pair IABP-SHOCK II trial 30-day mortality analysis. Circulation 139:1249\u20131258","journal-title":"Circulation"},{"issue":"8","key":"7618_CR129","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jama.2020.0254","volume":"323","author":"SS Dhruva","year":"2020","unstructured":"Dhruva SS et al (2020) Association of use of intravascular microaxial left ventricular assist device vs intra-aortic balloon pump on in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 323(8):734\u2013745","journal-title":"JAMA"},{"issue":"4","key":"7618_CR130","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/CIRCULATIONAHA.119.044007","volume":"141","author":"AP Amin","year":"2020","unstructured":"Amin AP et al (2020) The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation 141(4):273\u2013284","journal-title":"Circulation"},{"key":"7618_CR131","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2023.1643","author":"ZI Almarzooq","year":"2023","unstructured":"Almarzooq ZI et al (2023) Comparative effectiveness of percutaneous microaxial left ventricular assist device vs intra-aortic balloon pump or no mechanical circulatory support in patients with cardiogenic shock. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2023.1643","journal-title":"JAMA Cardiol"},{"key":"7618_CR132","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1001\/jamainternmed.2022.2735","volume":"182","author":"PE Miller","year":"2022","unstructured":"Miller PE et al (2022) Clinical outcomes and cost associated with an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump in patients presenting with acute myocardial infarction complicated by cardiogenic shock. JAMA Intern Med 182:926\u2013933","journal-title":"JAMA Intern Med"},{"issue":"3","key":"7618_CR133","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ccd.29834","volume":"99","author":"Y Kim","year":"2022","unstructured":"Kim Y et al (2022) Outcomes of mechanical circulatory support for acute myocardial infarction complicated by cardiogenic shock. Catheter Cardiovasc Interv 99(3):658\u2013663","journal-title":"Catheter Cardiovasc Interv"},{"key":"7618_CR134","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ahj.2019.04.019","volume":"214","author":"NJ Udesen","year":"2019","unstructured":"Udesen NJ et al (2019) Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. Am Heart J 214:60\u201368","journal-title":"Am Heart J"},{"issue":"15","key":"7618_CR135","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1056\/NEJMoa2312572","volume":"390","author":"JE Moller","year":"2024","unstructured":"Moller JE et al (2024) Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med 390(15):1382\u20131393","journal-title":"N Engl J Med"},{"key":"7618_CR136","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/eurheartj\/ehx363","volume":"38","author":"H Thiele","year":"2017","unstructured":"Thiele H et al (2017) Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials. Eur Heart J 38:3523\u20133531","journal-title":"Eur Heart J"},{"key":"7618_CR137","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","volume":"26","author":"H Thiele","year":"2005","unstructured":"Thiele H et al (2005) Randomized comparison of intraaortic balloon support versus a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26:1276\u20131283","journal-title":"Eur Heart J"},{"key":"7618_CR138","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/MAT.0000000000000709","volume":"64","author":"AK Ravichandran","year":"2018","unstructured":"Ravichandran AK et al (2018) Outcomes with the Tandem protek duo dual-lumen percutaneous right ventricular assist device. ASAIO J 64:570\u2013572","journal-title":"ASAIO J"},{"issue":"9","key":"7618_CR139","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s00134-023-07157-x","volume":"49","author":"AF Stephens","year":"2023","unstructured":"Stephens AF et al (2023) ECMO PAL: using deep neural networks for survival prediction in venoarterial extracorporeal membrane oxygenation. Intens Care Med 49(9):1090\u20131099","journal-title":"Intens Care Med"},{"issue":"12","key":"7618_CR140","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1007\/s00134-023-07199-1","volume":"49","author":"SM Fernando","year":"2023","unstructured":"Fernando SM et al (2023) Age and associated outcomes among patients receiving venoarterial extracorporeal membrane oxygenation\u2013analysis of the Extracorporeal Life Support Organization registry. Intens Care Med 49(12):1456\u20131466","journal-title":"Intens Care Med"},{"issue":"2","key":"7618_CR141","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00134-023-07278-3","volume":"50","author":"CJW Low","year":"2024","unstructured":"Low CJW et al (2024) Mechanical circulatory support for cardiogenic shock: a network meta-analysis of randomized controlled trials and propensity score-matched studies. Intens Care Med 50(2):209\u2013221","journal-title":"Intens Care Med"},{"issue":"6","key":"7618_CR142","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.122.062949","volume":"147","author":"P Ostadal","year":"2023","unstructured":"Ostadal P et al (2023) Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: Results of the ECMO-CS Randomized Clinical Trial. Circulation 147(6):454\u2013464","journal-title":"Circulation"},{"issue":"10410","key":"7618_CR143","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(23)01607-0","volume":"402","author":"U Zeymer","year":"2023","unstructured":"Zeymer U et al (2023) Veno-arterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock - an individual patient data meta-analysis of randomised trials. Lancet 402(10410):1338\u20131346","journal-title":"Lancet"},{"issue":"3","key":"7618_CR144","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/CCM.0000000000006179","volume":"52","author":"RR Ling","year":"2024","unstructured":"Ling RR, Low CJW, Ramanathan K (2024) Mechanical left-ventricular unloading in extracorporeal cardiopulmonary resuscitation: a state of clinical equipoise. Crit Care Med 52(3):512\u2013515","journal-title":"Crit Care Med"},{"issue":"7","key":"7618_CR145","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ccd.28307","volume":"93","author":"MB Basir","year":"2019","unstructured":"Basir MB et al (2019) Improved outcomes associated with the use of shock protocols: Updates from the National Cardiogenic Shock Initiative. Cathet Cardiovasc Interv 93(7):1173\u20131183","journal-title":"Cathet Cardiovasc Interv"},{"issue":"1","key":"7618_CR146","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13054-024-04988-y","volume":"28","author":"D De Backer","year":"2024","unstructured":"De Backer D et al (2024) Mechanical circulatory support in cardiogenic shock: microaxial flow pumps for all and VA-ECMO consigned to the museum? Crit Care 28(1):203","journal-title":"Crit Care"},{"issue":"1","key":"7618_CR147","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13613-023-01130-z","volume":"13","author":"H Merdji","year":"2023","unstructured":"Merdji H et al (2023) Microcirculatory dysfunction in cardiogenic shock. Ann Intens Care 13(1):38","journal-title":"Ann Intens Care"},{"issue":"6","key":"7618_CR148","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00134-023-07098-5","volume":"49","author":"RR Bruno","year":"2023","unstructured":"Bruno RR et al (2023) Direct assessment of microcirculation in shock: a randomized-controlled multicenter study. Intens Care Med 49(6):645\u2013655","journal-title":"Intens Care Med"},{"issue":"11","key":"7618_CR149","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00134-023-07213-6","volume":"49","author":"T Tschoellitsch","year":"2023","unstructured":"Tschoellitsch T et al (2023) The value of clinical signs as indicators of shock. Intens Care Med 49(11):1413\u20131415","journal-title":"Intens Care Med"},{"issue":"1","key":"7618_CR150","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s13054-023-04752-8","volume":"27","author":"M Buckel","year":"2023","unstructured":"Buckel M et al (2023) Extending the \u2018host response\u2019 paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities. Crit Care 27(1):460","journal-title":"Crit Care"},{"issue":"11","key":"7618_CR151","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s00134-021-06537-5","volume":"47","author":"PF Laterre","year":"2021","unstructured":"Laterre PF et al (2021) Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial. Intens Care Med 47(11):1284\u20131294","journal-title":"Intens Care Med"},{"key":"7618_CR152","doi-asserted-by":"publisher","first-page":"1058235","DOI":"10.3389\/fmed.2022.1058235","volume":"9","author":"D van Lier","year":"2022","unstructured":"van Lier D et al (2022) Effects of enrichment strategies on outcome of adrecizumab treatment in septic shock: Post-hoc analyses of the phase II adrenomedullin and outcome in septic shock 2 trial. Front Med (Lausanne) 9:1058235","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"7618_CR153","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","volume":"49","author":"J Helms","year":"2023","unstructured":"Helms J et al (2023) How to manage coagulopathies in critically ill patients. Intens Care Med 49(3):273\u2013290","journal-title":"Intens Care Med"},{"key":"7618_CR154","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00134-023-07298-z","volume":"50","author":"B Guidet","year":"2024","unstructured":"Guidet B et al (2024) The trajectory of very old critically ill patients. Intens Care Med 50:181\u2013194","journal-title":"Intens Care Med"}],"container-title":["Intensive Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00134-024-07618-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00134-024-07618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T08:06:33Z","timestamp":1730880393000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00134-024-07618-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":154,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7618"],"URL":"https:\/\/doi.org\/10.1007\/s00134-024-07618-x","relation":{},"ISSN":["0342-4642","1432-1238"],"issn-type":[{"value":"0342-4642","type":"print"},{"value":"1432-1238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CJ reports institutional grants by the German research foundation, German ministry for economy and energy, State of Nordrhine-Westfalia, German space agency, European Union and Edwards Lifescience as well as speaker fees outside the field of this article by Bristol Myers Squibb, Daichi Sankyo and Boehringer-Ingelheim. RRB: no conflict of interest. MJ: no conflict of interest. SP: no conflict of interest. KAK reports speaker fees received from Daiichi Sankyo, Zoll Medical, Amarin, consulting fees by Amarin, Novartis, Sanofi and travel support provided by Amgen, Sanofi and Daiichi Sankyo. KR reports that he is the current Chair of Publications at the Extracorporeal Life Support Organisation. JD: no conflict of interest. JF: no conflict of interest. Clement Delmas reports lectures and consulting fees received by Abiomed and Abott. A-AM: no conflict of interest. HT: no conflict of interest. SS: no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}